Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma.

Journal of Neuro-oncology
Johannes E A WolffStefaan W Van Gool

Abstract

The prognosis of high-grade glioma in children is poor. Interferon-gamma may increase the immune surveillance of glioma cells. Earlier clinical evidence had shown that low dose cyclophosphamide (CPM) increased immune response. After induction treatment with simultaneous radiation and chemotherapy, patients were treated with individually increasing interferon-gamma (IFN-gamma) doses starting from 25 microg/m2/d s.c. increasing up to a maximum of 175 microg/m2/d within 7 weeks. Cyclophosphamide was given at 300 mg/m2 i.v. every 21 days. Forty pediatric glioma patients were enrolled (median age: 8.5 year, male: n = 22). Tumor locations included cerebral cortex (n = 8), basal ganglia (n = 4), brainstem (n = 24), cerebellum (n = 3), spinal cord (n = 1). Histologies were GBM (n = 14), AA (n = 14), LGG (n = 2, diffuse intrinsic pontine glioma). There was grade IV toxicity for thrombocytopenia (10%) and leucopenia (2.5%), grade III toxicity for central nervous (2.5%) and hepatic (5%) side effects, no toxic death. The observation time of the six surviving patients was: 1.2, 1.9, 4.2, 4.4, 4.6 and 4.7 years respectively. The median overall survival (1 year) was not significantly different from a historical control group (0.8 years). The ...Continue Reading

References

Jul 1, 1990·Clinical and Experimental Immunology·M C KuppnerN de Tribolet
Apr 1, 1990·Controlled Clinical Trials·W D Dupont, W D Plummer
Dec 1, 1988·Journal of Neurosurgery·M S MahaleyG Y Gillespie
Jan 1, 1994·Annals of Surgical Oncology·T M TuttleH D Bear
Jul 1, 1993·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·J S AbramsJ Aisner
Oct 31, 1996·Nature·A K AbbasA Sher
Jan 1, 1997·Annual Review of Immunology·E A BachR D Schreiber
Jul 1, 1997·Immunology Letters·N ThiounnB Debré
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·G Beatty, Y Paterson
Jan 30, 2002·Cancer·Johannes E A WolffJoachim Kühl
Apr 13, 2002·Journal of Neuro-oncology·Jean-Jacques DubostPierre Verrelle
Oct 18, 2002·Cancer Immunology, Immunotherapy : CII·Keith DredgeAngus G Dalgleish
Nov 16, 2002·British Journal of Cancer·J E A WolffJ Kuehl
Apr 22, 2003·Journal of Cellular Physiology·M A Santana, Y Rosenstein

❮ Previous
Next ❯

Citations

Apr 16, 2019·The Cochrane Database of Systematic Reviews·Renée L MulderElvira C van Dalen
Jul 23, 2013·British Journal of Cancer·M KarremannC M Kramm
Oct 4, 2017·Oncotarget·Moatasem El-AyadiAndre O von Bueren
May 8, 2008·Current Neurology and Neuroscience Reports·Kevin C De Braganca, Roger J Packer
Dec 7, 2007·Neuropathology and Applied Neurobiology·V VladimirovaT Pietsch
Aug 10, 2010·Journal of Neuro-oncology·Johannes E WolffChristoph Kramm
Jul 27, 2010·Pediatric Blood & Cancer·Johannes E A WolffAstrid Gnekow
Jun 3, 2015·Neuro-oncology Practice·Magimairajan Issai Vanan, David D Eisenstat
Sep 29, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Sabine WagnerLaszlo K Csatary
May 13, 2009·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Carlos E A BatistaDiane C Chugani
Jun 10, 2011·Neurosurgical Review·Kenichiro IwamiToshihiko Wakabayashi
May 31, 2013·Paediatric Drugs·Rejin Kebudi, Fatma Betul Cakir
Jul 8, 2011·The Cochrane Database of Systematic Reviews·Renée L MulderLeontien Cm Kremer
Dec 23, 2011·Clinical & Developmental Immunology·Christopher JacksonMichael Lim
Jan 23, 2008·Journal of Neuro-oncology·Johannes E A WolffChristof M Kramm
Aug 6, 2008·Journal of Neuro-oncology·Johannes E A WolffPablo Hernáiz Driever
Nov 12, 2015·Frontiers in Oncology·Magimairajan Issai Vanan, David D Eisenstat
Jun 22, 2016·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Or Cohen-Inbar, Menashe Zaaroor
Jun 20, 2020·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Ciaran Scott HillKristian Aquilina
Dec 2, 2008·Journal of Neuro-oncology·Michael KarremannJohannes E A Wolff
Dec 4, 2008·Neuro-oncology·Michael KarremannChristof M Kramm
Jan 19, 2013·Paediatric Drugs·Trent R HummelDavid Franz
Oct 2, 2007·Current Opinion in Oncology·Jacques Grill, Ranjeev Bhangoo
Jun 4, 2011·Neuro-oncology·Christof M KrammJohannes E Wolff
Aug 4, 2015·Pediatric Hematology and Oncology·Michael KarremannChristof M Kramm
Feb 12, 2020·Cancer Letters·Shengchao XuZhixiong Liu
Feb 7, 2018·Cellular Immunology·Barbara DillingerAlexander M Dohnal
May 1, 2021·Cancers·Aleksandra NapieralskaMaciej Harat
Jul 4, 2021·Neurologic Clinics·Fatema Malbari
Sep 1, 2021·Zhurnal voprosy neĭrokhirurgii imeni N. N. Burdenko·S S OzerovE V Kumirova
Jul 4, 2012·Neurosurgery Clinics of North America·Jacob RuzevickMichael Lim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.